Bbraun

B. Braun manufactures a portfolio of infusion pumps, administration systems, and clinical networked devices spanning products such as Infusomat, SpaceCom, and DataModule platforms, which are deployed in hospital environments where reliability and security directly impact patient safety. Vulnerabilities affecting the vendor skew toward serious outcomes, with a meaningful share reaching critical severity, and recur across this medical-device portfolio through weakness classes including improper cryptographic signature verification, path traversal, open redirects, active debug code, and cleartext transmission of sensitive data—patterns consistent with legacy embedded medical software and networked clinical infrastructure. The exposure in medical devices reflects particular risk given the difficulty of patching deployed systems in healthcare settings and the potential for these flaws to compromise drug-delivery precision and clinical-workflow integrity. Defenders managing B. Braun infrastructure should prioritize network segmentation, inventory affected device models and firmware versions, and coordinate with their biomedical teams on patch availability and deployment constraints; live severity, exploitation, and exposure counts are shown alongside this summary.